BioNTech SE
NASDAQ:BNTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
V
|
Visa Inc
SWB:3V64
|
US |
|
Jtc PLC
LSE:JTC
|
JE |
|
L
|
Lattice Semiconductor Corp
F:LTT
|
US |
|
Hermes International SCA
PAR:RMS
|
FR |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
T
|
Teixeira Duarte SA
ELI:TDSA
|
PT |
|
Construction Partners Inc
NASDAQ:ROAD
|
US |
|
Caliber Imaging & Diagnostics Inc
OTC:LCDX
|
US |
|
E
|
ENGIE Energia Chile SA
SGO:ECL
|
CL |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
Technoprobe SpA
F:K8B
|
IT |
Wall St Price Targets
BNTX Price Targets Summary
BioNTech SE
According to Wall Street analysts, the average 1-year price target for
BNTX is 131.43 USD with a low forecast of 82.93 USD and a high forecast of 190.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BNTX's stock price target?
Price Target
131.43
USD
According to Wall Street analysts, the average 1-year price target for
BNTX is 131.43 USD with a low forecast of 82.93 USD and a high forecast of 190.05 USD.
What is the Revenue forecast for BioNTech SE?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 8%.